Your browser doesn't support javascript.
Hypofractionated radiotherapy for nonmelanoma skin cancer during the COVID-19 pandemic: experience in 31 cases.
Piccinno, Roberta; Berti, Emilio; Barei, Francesca.
  • Piccinno R; UOC Dermatologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Berti E; UOC Dermatologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Barei F; Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Università degli Studi di Milano, Milan, Italy.
Tumori ; 108(4): 394-396, 2022 Aug.
Article in English | MEDLINE | ID: covidwho-1477149
ABSTRACT
As a result of the coronavirus disease 2019 (COVID-19) pandemic, radiation therapies have been modulated to reduce the risk of infection during outpatient activities and hypofractionated regimens or radiotherapy delay for nonmelanoma skin cancer (NMSC) were suggested. Hypofractionated radiotherapy not only may confer no disadvantage in regard to outcome when compared to a more protracted schedule but might also reduce the risk of infection. We report the experience of a dermatologic radiation therapy department concerning a group of patients with a diagnosis of NMSC selected for a radiation treatment plan aimed to minimize the number of their accesses to our department.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Skin Neoplasms / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Tumori Year: 2022 Document Type: Article Affiliation country: 03008916211051426

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Skin Neoplasms / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Tumori Year: 2022 Document Type: Article Affiliation country: 03008916211051426